Antiviral agents against equid alphaherpesviruses : current status and perspectives

Autores
Thiry, Etienne; Dal Pozzo, Fabiana; Barrandeguy, Maria Edith; Vissani, Maria Aldana
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión aceptada
Descripción
Equid herpesvirus infections cause respiratory, neurological and reproductive syndromes. Despite preventive and control measures and the availability of vaccines and immunostimulants, herpesvirus infections still constitute a major threat to equine health and for the equine industry worldwide. Antiviral drugs, particularly nucleoside analogues and foscarnet, are successfully used for the treatment of human alphaherpesvirus infections. In equine medicine, the use of antiviral medications in alphaherpesvirus infections would decrease the excretion of virus and diminish the risk of contagion and the convalescent time in affected horses, and would also improve the clinical outcome of equine herpesvirus myeloencephalopathy. The combined use of antiviral compounds, along with vaccines, immune modulators, and effective preventive and control measures, might be beneficial in diminishing the negative impact of alphaherpesvirus infections in horses. The purpose of this review is to analyse the available information regarding the use of antiviral agents against alphaherpesviruses, with particular emphasis on equine alphaherpesvirus infections.
Inst.de Virología
Fil: Vissani, Aldana. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina
Fil: Thiry, Etienne. University of Liege. Faculty of Veterinary Medicine. Veterinary Virology and Animal Viral Diseases and UREAR. Department of Infectious and Parasitic Diseases; Bélgica
Fil: Dal Pozzo, Fabiana. University of Liege. Faculty of Veterinary Medicine. Veterinary Virology and Animal Viral Diseases and UREAR. Department of Infectious and Parasitic Diseases; Bélgica
Fil: Barrandeguy, Maria Edith. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Universidad del Salvador. Carrera de Veterinaria; Argentina
Fuente
Veterinary journal 207 : 38-44. (January 2016)
Materia
Enfermedades de los Animales
Viricidas
Alphavirus
Herpesviridae
Animal Diseases
Antiviral Agents
Herpesvirus
Alphaherpesvirus
Nivel de accesibilidad
acceso restringido
Condiciones de uso
Repositorio
INTA Digital (INTA)
Institución
Instituto Nacional de Tecnología Agropecuaria
OAI Identificador
oai:localhost:20.500.12123/1220
Acceder
id INTADig_ef0441821265520cc8681f9f5240df50
oai_identifier_str oai:localhost:20.500.12123/1220
network_acronym_str INTADig
repository_id_str l
network_name_str INTA Digital (INTA)
spelling Antiviral agents against equid alphaherpesviruses : current status and perspectivesThiry, EtienneDal Pozzo, FabianaBarrandeguy, Maria EdithVissani, Maria AldanaEnfermedades de los AnimalesViricidasAlphavirusHerpesviridaeAnimal DiseasesAntiviral AgentsHerpesvirusAlphaherpesvirusEquid herpesvirus infections cause respiratory, neurological and reproductive syndromes. Despite preventive and control measures and the availability of vaccines and immunostimulants, herpesvirus infections still constitute a major threat to equine health and for the equine industry worldwide. Antiviral drugs, particularly nucleoside analogues and foscarnet, are successfully used for the treatment of human alphaherpesvirus infections. In equine medicine, the use of antiviral medications in alphaherpesvirus infections would decrease the excretion of virus and diminish the risk of contagion and the convalescent time in affected horses, and would also improve the clinical outcome of equine herpesvirus myeloencephalopathy. The combined use of antiviral compounds, along with vaccines, immune modulators, and effective preventive and control measures, might be beneficial in diminishing the negative impact of alphaherpesvirus infections in horses. The purpose of this review is to analyse the available information regarding the use of antiviral agents against alphaherpesviruses, with particular emphasis on equine alphaherpesvirus infections.Inst.de VirologíaFil: Vissani, Aldana. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; ArgentinaFil: Thiry, Etienne. University of Liege. Faculty of Veterinary Medicine. Veterinary Virology and Animal Viral Diseases and UREAR. Department of Infectious and Parasitic Diseases; BélgicaFil: Dal Pozzo, Fabiana. University of Liege. Faculty of Veterinary Medicine. Veterinary Virology and Animal Viral Diseases and UREAR. Department of Infectious and Parasitic Diseases; BélgicaFil: Barrandeguy, Maria Edith. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Universidad del Salvador. Carrera de Veterinaria; Argentina2017-09-14T14:20:56Z2017-09-14T14:20:56Z2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/20.500.12123/1220http://www.sciencedirect.com/science/article/pii/S10900233150025431090-0233https://doi.org/10.1016/j.tvjl.2015.06.010Veterinary journal 207 : 38-44. (January 2016)reponame:INTA Digital (INTA)instname:Instituto Nacional de Tecnología Agropecuariaenginfo:eu-repo/semantics/restrictedAccess2025-09-04T09:47:01Zoai:localhost:20.500.12123/1220instacron:INTAInstitucionalhttp://repositorio.inta.gob.ar/Organismo científico-tecnológicoNo correspondehttp://repositorio.inta.gob.ar/oai/requesttripaldi.nicolas@inta.gob.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:l2025-09-04 09:47:02.47INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuariafalse
dc.title.none.fl_str_mv Antiviral agents against equid alphaherpesviruses : current status and perspectives
title Antiviral agents against equid alphaherpesviruses : current status and perspectives
spellingShingle Antiviral agents against equid alphaherpesviruses : current status and perspectives
Thiry, Etienne
Enfermedades de los Animales
Viricidas
Alphavirus
Herpesviridae
Animal Diseases
Antiviral Agents
Herpesvirus
Alphaherpesvirus
title_short Antiviral agents against equid alphaherpesviruses : current status and perspectives
title_full Antiviral agents against equid alphaherpesviruses : current status and perspectives
title_fullStr Antiviral agents against equid alphaherpesviruses : current status and perspectives
title_full_unstemmed Antiviral agents against equid alphaherpesviruses : current status and perspectives
title_sort Antiviral agents against equid alphaherpesviruses : current status and perspectives
dc.creator.none.fl_str_mv Thiry, Etienne
Dal Pozzo, Fabiana
Barrandeguy, Maria Edith
Vissani, Maria Aldana
author Thiry, Etienne
author_facet Thiry, Etienne
Dal Pozzo, Fabiana
Barrandeguy, Maria Edith
Vissani, Maria Aldana
author_role author
author2 Dal Pozzo, Fabiana
Barrandeguy, Maria Edith
Vissani, Maria Aldana
author2_role author
author
author
dc.subject.none.fl_str_mv Enfermedades de los Animales
Viricidas
Alphavirus
Herpesviridae
Animal Diseases
Antiviral Agents
Herpesvirus
Alphaherpesvirus
topic Enfermedades de los Animales
Viricidas
Alphavirus
Herpesviridae
Animal Diseases
Antiviral Agents
Herpesvirus
Alphaherpesvirus
dc.description.none.fl_txt_mv Equid herpesvirus infections cause respiratory, neurological and reproductive syndromes. Despite preventive and control measures and the availability of vaccines and immunostimulants, herpesvirus infections still constitute a major threat to equine health and for the equine industry worldwide. Antiviral drugs, particularly nucleoside analogues and foscarnet, are successfully used for the treatment of human alphaherpesvirus infections. In equine medicine, the use of antiviral medications in alphaherpesvirus infections would decrease the excretion of virus and diminish the risk of contagion and the convalescent time in affected horses, and would also improve the clinical outcome of equine herpesvirus myeloencephalopathy. The combined use of antiviral compounds, along with vaccines, immune modulators, and effective preventive and control measures, might be beneficial in diminishing the negative impact of alphaherpesvirus infections in horses. The purpose of this review is to analyse the available information regarding the use of antiviral agents against alphaherpesviruses, with particular emphasis on equine alphaherpesvirus infections.
Inst.de Virología
Fil: Vissani, Aldana. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina
Fil: Thiry, Etienne. University of Liege. Faculty of Veterinary Medicine. Veterinary Virology and Animal Viral Diseases and UREAR. Department of Infectious and Parasitic Diseases; Bélgica
Fil: Dal Pozzo, Fabiana. University of Liege. Faculty of Veterinary Medicine. Veterinary Virology and Animal Viral Diseases and UREAR. Department of Infectious and Parasitic Diseases; Bélgica
Fil: Barrandeguy, Maria Edith. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Universidad del Salvador. Carrera de Veterinaria; Argentina
description Equid herpesvirus infections cause respiratory, neurological and reproductive syndromes. Despite preventive and control measures and the availability of vaccines and immunostimulants, herpesvirus infections still constitute a major threat to equine health and for the equine industry worldwide. Antiviral drugs, particularly nucleoside analogues and foscarnet, are successfully used for the treatment of human alphaherpesvirus infections. In equine medicine, the use of antiviral medications in alphaherpesvirus infections would decrease the excretion of virus and diminish the risk of contagion and the convalescent time in affected horses, and would also improve the clinical outcome of equine herpesvirus myeloencephalopathy. The combined use of antiviral compounds, along with vaccines, immune modulators, and effective preventive and control measures, might be beneficial in diminishing the negative impact of alphaherpesvirus infections in horses. The purpose of this review is to analyse the available information regarding the use of antiviral agents against alphaherpesviruses, with particular emphasis on equine alphaherpesvirus infections.
publishDate 2016
dc.date.none.fl_str_mv 2016
2017-09-14T14:20:56Z
2017-09-14T14:20:56Z
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12123/1220
http://www.sciencedirect.com/science/article/pii/S1090023315002543
1090-0233
https://doi.org/10.1016/j.tvjl.2015.06.010
url http://hdl.handle.net/20.500.12123/1220
http://www.sciencedirect.com/science/article/pii/S1090023315002543
https://doi.org/10.1016/j.tvjl.2015.06.010
identifier_str_mv 1090-0233
dc.language.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/restrictedAccess
eu_rights_str_mv restrictedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Veterinary journal 207 : 38-44. (January 2016)
reponame:INTA Digital (INTA)
instname:Instituto Nacional de Tecnología Agropecuaria
reponame_str INTA Digital (INTA)
collection INTA Digital (INTA)
instname_str Instituto Nacional de Tecnología Agropecuaria
repository.name.fl_str_mv INTA Digital (INTA) - Instituto Nacional de Tecnología Agropecuaria
repository.mail.fl_str_mv tripaldi.nicolas@inta.gob.ar
_version_ 1842341350161252352
score 12.623145

Publicaciones similares